• Login
    JavaScript is disabled for your browser. Some features of this site may not work without it.
    Pharmacometrically Driven Optimisation of Dose Regimens in Clinical Trials 
    •   QMRO Home
    • Queen Mary University of London Theses
    • Theses
    • Pharmacometrically Driven Optimisation of Dose Regimens in Clinical Trials
    •   QMRO Home
    • Queen Mary University of London Theses
    • Theses
    • Pharmacometrically Driven Optimisation of Dose Regimens in Clinical Trials
    ‌
    ‌

    Browse

    All of QMROCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects
    ‌
    ‌

    Administrators only

    Login
    ‌
    ‌

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular Authors

    Pharmacometrically Driven Optimisation of Dose Regimens in Clinical Trials

    View/Open
    SOENY_Kabir_PhD_Final_040517.pdf (4.604Mb)
    Publisher
    Queen Mary University of London
    Metadata
    Show full item record
    Abstract
    The dose regimen of a drug gives important information about the dose sizes, dose frequency and the duration of treatment. Optimisation of dose regimens is critical to ensure therapeutic success of the drug and to minimise its possible adverse effects. The central theme of this thesis is the Efficient Dosing (ED) algorithm - a computation algorithm developed by us for optimisation of dose regimens. In this thesis, we have attempted to develop a quantitative framework for measuring the efficiency of a dose regimen for specified criteria and computing the most efficient dose regimen using the ED algorithm. The criteria considered by us seek to prevent over- and under-exposure to the drug. For example, one of the criteria is to maintain the drug's concentration around a desired target level. Another criterion is to maintain the concentration within a therapeutic range or window. The ED algorithm and its various extensions are programmed in MATLAB R . Some distinguishing features of our methods are: mathematical explicitness in the optimisation process for a general objective function, creation of a theoretical base to draw comparisons among competing dose regimens, adaptability to any drug for which the PK model is known, and other computational features. We develop the algorithm further to compute the optimal ratio of two partner drugs in a fixed dose combination unit and the efficient dose regimens. In clinical trials, the parameters of the PK model followed by the drug are often unknown. We develop a methodology to apply our algorithm in an adaptive setting which enables estimation of the parameters while optimising the dose regimens for the typical subject in each cohort. A potential application of the ED algorithm for individualisation of dose regimens is discussed. We also discuss an application for computation of efficient dose regimens for obliteration of a pre-specified viral load.
    Authors
    Soeny, Kabir
    URI
    http://qmro.qmul.ac.uk/xmlui/handle/123456789/25822
    Collections
    • Theses [3651]
    Licence information
    The copyright of this thesis rests with the author and no quotation from it or information derived from it may be published without the prior written consent of the author
    Twitter iconFollow QMUL on Twitter
    Twitter iconFollow QM Research
    Online on twitter
    Facebook iconLike us on Facebook
    • Site Map
    • Privacy and cookies
    • Disclaimer
    • Accessibility
    • Contacts
    • Intranet
    • Current students

    Modern Slavery Statement

    Queen Mary University of London
    Mile End Road
    London E1 4NS
    Tel: +44 (0)20 7882 5555

    © Queen Mary University of London.